Home › Mitochondrial Myopathies › NCT05250375
Natural History Study of Mitochondrial Myopathy
Who can join
Ages 0 to 100 · All sexes · Healthy volunteers welcome
Full eligibility criteria
MM Cohort Inclusion Criteria 1. Males or females age 0-100 years of age 2. Mitochondrial disorder established by confirmed genetic or biochemical mutation in mtDNA or nuclear DNA OR is suitable for participation in the opinion of the investigator based on clinical presentation. 3. Exhibits myopathy (exercise intolerance, muscle strength, fatigue) relating to Mitochondrial disease in the opinion of the investigator 4. Able to provide written consent OR parental permission and child assent OR if they are an adult with diminished capacity, an LAR or healthcare representative is able to and willing to provide consent ., as approved by the appropriate Institutional Review Board (IRB) or Ethics Committee (EC) MM Cohort Exclusion Criteria 1. Male or female fetuses 2. Non English speakers 3. Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures. 4. Subjects that do not meet all of the enrollment criteria may not be enrolled. Any violations of these criteria must be reported in accordance with IRB Policies and Procedures. Healthy Control Cohort Inclusion Criteria 1. Males or females age 0-100 years of age 2. No history of mitochondrial myopathy symptoms 3. Able to provide written consent or parental permission and child assent., approved by the appropriate Institutional Review Board (IRB) or Ethics Committee (EC) 4. Individual is not a study staff member or a family member of a study staff member (not listed as a study staff in eIRB) Healthy Control Exclusion Criteria 1. Male or female fetuses 2. Non English speakers 3. Mitochondrial disorder established by confirmed genetic or biochemical mutation in mtDNA or nuclear DNA 4. Exhibits myopathy (exercise intolerance, muscle strength, fatigue) relating to Mitochondrial disease 5. Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures. 6. Individual is listed as a study staff member in eIRB, OR individual is a family member of a study staff member listed in eIRB 7. Subjects that do not meet all of the enrollment criteria may not be enrolled. Any violations of these criteria must be reported in accordance with IRB Policies and Procedures.
About the study
The goal of this observational study is to develop and validate tools to measure disease course in patients with primary mitochondrial myopathy (PMM). The main aims of this study are:
* Development, validation, and optimization of objective outcome measures for mitochondrial myopathy * Defining the natural history of mitochondrial myopathy
Researchers will compare data from patients with primary mitochondrial myopathy to healthy controls. Data from healthy controls will also help define normative data for future studies.
Participants will perform clinical exams of muscle strength and endurance and will complete surveys.
Sponsor: Children's Hospital of Philadelphia · Participants: 1,300 · Started: Mar 24, 2017
Contact the study team
- Katelynn Stanley, BS · Phone: 267 426 4961
- Jean Flickinger, PT · Phone: 267 426 4961
Official record on ClinicalTrials.gov — NCT05250375
Locations in the U.S.
| Pennsylvania | Children's Hospital of Philadelphia, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.